Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2 - Wikidata - awgldk - TriplyDB

Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2

Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2

http://www.wikidata.org/entity/Q28291091

about

A potential role of alternative splicing in the regulation of the transcriptional activity of human GLI2 in gonadal tissues.GLI2-specific transcriptional activation of the bone morphogenetic protein/activin antagonist follistatin in human epidermal cells Disruption of Vitamin D and Calcium Signaling in Keratinocytes Predisposes to Skin Cancer The Potential Role of Hedgehog Signaling in the Luminal/Basal Phenotype of Breast Epithelia and in Breast Cancer Invasion and Metastasis Signal transduction in the chronic leukemias: implications for targeted therapies Context-dependent signal integration by the GLI code: the oncogenic load, pathways, modifiers and implications for cancer therapy Arsenic trioxide prevents osteosarcoma growth by inhibition of GLI transcription via DNA damage accumulation Structural and logical analysis of a comprehensive hedgehog signaling pathway to identify alternative drug targets for glioma, colon and pancreatic cancer Novel Acylguanidine Derivatives Targeting Smoothened Induce Antiproliferative and Pro-Apoptotic Effects in Chronic Myeloid Leukemia Cells Gli-1 siRNA induced apoptosis in Huh7 cells.Novel sequential ChIP and simplified basic ChIP protocols for promoter co-occupancy and target gene identification in human embryonic stem cells.Non-consensus GLI binding sites in Hedgehog target gene regulation.New hedgehog/GLI-signaling inhibitors from Adenium obesum.The vitamin D receptor: a tumor suppressor in skin.KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma.Hedgehog inhibition promotes a switch from Type II to Type I cell death receptor signaling in cancer cells Targeting Hedgehog--a cancer stem cell pathway Vitamin D and the skin: Physiology and pathophysiology.Betulinic acid induces apoptosis and inhibits hedgehog signalling in rhabdomyosarcoma.Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms.Stem cell pathways contribute to clinical chemoresistance in ovarian cancer GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft Expression of microRNAs in basal cell carcinoma.Protective actions of vitamin D in UVB induced skin cancer.Protective role of vitamin D signaling in skin cancer formation.The Gli code: an information nexus regulating cell fate, stemness and cancer.Integrated genotypic analysis of hedgehog-related genes identifies subgroups of keratocystic odontogenic tumor with distinct clinicopathological features Hedgehog signaling regulates telomerase reverse transcriptase in human cancer cells The protective role of vitamin d signaling in non-melanoma skin cancer.The hedgehog/Gli signaling paradigm in prostate cancer Hedgehog signaling inhibitor cyclopamine induces apoptosis by decreasing Gli2 and Bcl2 expression in human salivary pleomorphic adenoma cells.The alpha subunit of the G protein G13 regulates activity of one or more Gli transcription factors independently of smoothened.Overexpression of hedgehog signaling is associated with epidermal tumor formation in vitamin D receptor-null mice Hedgehog signaling promotes medulloblastoma survival via Bc/II Basal cell carcinomas: attack of the hedgehog.MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1.A genome scale RNAi screen identifies GLI1 as a novel gene regulating vorinostat sensitivity.Gli2 silencing enhances TRAIL-induced apoptosis and reduces tumor growth in human hepatoma cells in vivo A model of spatially restricted transcription in opposing gradients of activators and repressors A role for transcription factor STAT3 signaling in oncogene smoothened-driven carcinogenesis.

P2860

Q24309518-696FF24E-6CBC-400B-A67D-1699C74B0385 Q24653046-AC1A9190-E340-4341-8937-BED29B411A91 Q26741417-CF6C48B0-2A9D-45E5-AD57-4246254F0E52 Q26782727-1DA0910F-FC51-4C49-938B-7A39AA322305 Q27026031-159B31D8-DFC4-457C-8740-42C6E5514013 Q27027214-90198DE1-BD8A-4B6A-886B-28B442442714 Q28534552-ED13C27A-73DE-4A09-85C6-24730B43D479 Q28534771-B29FC057-6B96-4EF2-AC3F-8A71906B7B12 Q28550487-F7CDE72C-E830-449B-91CD-C5413DE350E4 Q33315283-CAF6124F-442D-4DE1-B5EB-D48099B30B4A Q33475969-F92EBC8D-A5C3-4F7A-BF39-AE9B4C474DF2 Q33523633-5FE6A069-FFE9-42E2-90EF-3F07BCF11268 Q33775728-FE3F0663-9F6D-4AD7-B172-7D4EAD81259D Q33806485-4265C705-92A4-4B1E-B150-2F8526B526D9 Q33858490-FE513F0B-1977-471E-9489-73396E053A52 Q33869744-4271AB09-25E5-4F74-A6FC-B720BA3E2D2F Q33925257-87BD32A8-A34E-45CE-AE22-688386D7EC0C Q33993788-CFFD00CF-972A-4D08-94B3-D82273E71077 Q34000246-39120F53-DA76-422C-980B-6A661024FB57 Q34075584-58E2070D-BB24-44D4-94B0-AAD25D5FDF50 Q34092005-295A1631-49A9-46EB-95E7-FE8F44A2C365 Q34129830-C756C354-6B53-49D8-9422-BD1771B56FC3 Q34271420-1ACBFFDA-F01A-4F53-90C3-7BF03E334BF5 Q34418244-5F42DE9B-0120-49AD-9D81-C64FCC416D17 Q34443888-F049E9BB-9F02-48EB-B8C3-98D6E00103EC Q34685494-7B2D44BD-8184-402A-892E-06AE07C0265B Q34948316-0A9012E2-A06F-4F7B-B095-6594C54EBB34 Q35005479-F02AB023-6199-47DC-9021-F47522321424 Q35033717-D4903502-68B1-4B40-9D23-29A8493DFBAA Q35109835-86F8EA9A-DAC9-42E3-918D-22AAFFEF0C58 Q35125622-306CDE86-229F-46CB-A39D-BB408813434E Q35182945-B3B5A37F-0AC6-42DF-A322-F19441B3ADDF Q35349544-CC1C4FFA-72E6-4D24-BB8E-AFDD1E0F2140 Q35570435-459EDA2B-2BCD-4B36-AB34-BD7D2D175786 Q35687900-5E7DD958-103A-47AE-8293-014E8380A004 Q35891213-4CCFEC6F-57B8-4360-8567-993717EFBB98 Q35921565-C1E9BE12-2F5C-4468-8D30-33F8CA6740FA Q36214554-6142B528-8E17-4747-AFE7-097C4498F301 Q36321629-264B2B9E-6401-492B-A689-C619B6598650 Q36368350-A0E82A19-5D42-43B4-B924-38A443F04F0F

P2860

Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2

http://www.wikidata.org/entity/Q28291091

description

2004 nî lūn-bûn

@nan

2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Activation of the BCL2 promote ...... predominantly mediated by GLI2

@ast

Activation of the BCL2 promote ...... predominantly mediated by GLI2

@en

Activation of the BCL2 promote ...... predominantly mediated by GLI2

@nl

type

label

Activation of the BCL2 promote ...... predominantly mediated by GLI2

@ast

Activation of the BCL2 promote ...... predominantly mediated by GLI2

@en

Activation of the BCL2 promote ...... predominantly mediated by GLI2

@nl

prefLabel

Activation of the BCL2 promote ...... predominantly mediated by GLI2

@ast

Activation of the BCL2 promote ...... predominantly mediated by GLI2

@en

Activation of the BCL2 promote ...... predominantly mediated by GLI2

@nl

P1433

Q28291091-F8CFC7D4-7FF4-4D29-902E-46A053C2A948

P1476

Q28291091-496A1C64-A008-4C33-85AA-12C37DDA78C0

P2093

Q28291091-18320127-70BE-4DC6-86AC-3E730BE3487D

Q28291091-3FE3FA84-F34B-4F1C-A37F-E1125D995274

Q28291091-4BA7CC25-677D-4729-A115-F2FBD7DF4BB7

Q28291091-5AB592A2-4CD1-412E-8157-5FDC02DDDEFE

Q28291091-715CD822-4C7F-41BB-B5A8-C1982A3A2787

Q28291091-7963E9C0-9380-42BC-8400-67827AC73F83

Q28291091-8E75616D-D0FA-4644-82DE-03D86F047151

Q28291091-A1EEDECF-142B-498B-B12E-41CC7E199734

Q28291091-DBB4155E-4ACA-4A29-A609-32A475F3421F

Q28291091-DFE2D696-6953-470D-B914-8C201F8A9E0F

P304

Q28291091-B2D566B2-444D-4554-90F7-3CA0AB7D5281

P31

Q28291091-44966564-7AF3-4571-B3CC-93D3013B54D0

P3181

Q28291091-B1FBD2C1-1393-4BB8-9AB8-D5DC21E260C8

P356

Q28291091-056CDE14-A7C9-439C-803E-D0CBD3F6C531

P407

Q28291091-08FEE810-0AB6-4F73-A41B-689384B69C15

P433

Q28291091-FDED65A7-96D6-4B12-A8BF-0A6E78172040

P478

Q28291091-0F841381-B979-45E1-8AEE-B274DB1A1F7D

P577

Q28291091-B0506D7C-1BA2-4466-872D-FDE81F3187D7

P698

Q28291091-CDCA770F-3936-4A35-956E-4EC295B3566E

P3181

P356

0008-5472.CAN-04-1085

P1433

Cancer Research

P1476

Activation of the BCL2 promote ...... predominantly mediated by GLI2

@en

P2093

Anna-Maria Frischauf

http://www.w3.org/2001/XMLSchema#string

Cornelia Hauser-Kronberger

http://www.w3.org/2001/XMLSchema#string

Fritz Aberger

http://www.w3.org/2001/XMLSchema#string

Gerhard Regl

http://www.w3.org/2001/XMLSchema#string

Graham W Neill

http://www.w3.org/2001/XMLSchema#string

Harald Esterbauer

http://www.w3.org/2001/XMLSchema#string

Harald Schnidar

http://www.w3.org/2001/XMLSchema#string

Maria Kasper

http://www.w3.org/2001/XMLSchema#string

Michael P Philpott

http://www.w3.org/2001/XMLSchema#string

Thomas Eichberger

http://www.w3.org/2001/XMLSchema#string

P304

7724-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4577428

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/0008-5472.CAN-04-1085

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15520176

http://www.w3.org/2001/XMLSchema#string